Proteolytic inhibitors: implications on microorganisms development, virulence and pathogenesis

Curr Med Chem. 2013;20(25):3035-40. doi: 10.2174/09298673113209990174.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Alveolata / drug effects
  • Alveolata / pathogenicity
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use
  • Bacteria / drug effects
  • Bacteria / pathogenicity
  • Communicable Diseases / drug therapy
  • Communicable Diseases / enzymology*
  • Communicable Diseases / pathology
  • Drug Resistance, Microbial
  • Euglenozoa / drug effects
  • Euglenozoa / pathogenicity
  • Fungi / drug effects
  • Fungi / pathogenicity
  • Humans
  • Peptide Hydrolases / chemistry
  • Peptide Hydrolases / metabolism
  • Protease Inhibitors / pharmacology
  • Protease Inhibitors / therapeutic use
  • Virulence / drug effects

Substances

  • Anti-Infective Agents
  • Protease Inhibitors
  • Peptide Hydrolases